BBI
Price:
$2.35
Market Cap:
$5.59M
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Car...[Read more]
Industry
Biotechnology
IPO Date
1993-03-10
Stock Exchange
NASDAQ
Ticker
BBI
According to Brickell Biotech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.60. This represents a change of 2.21% compared to the average of -0.24 of the last 4 quarters.
The mean historical PE Ratio of Brickell Biotech, Inc. over the last ten years is -1.84. The current -5.60 PE Ratio has changed 30.27% with respect to the historical average. Over the past ten years (40 quarters), BBI's PE Ratio was at its highest in in the September 2023 quarter at 0.68. The PE Ratio was at its lowest in in the September 2015 quarter at -35.25.
Average
-1.84
Median
-1.25
Minimum
-5.65
Maximum
-0.17
Discovering the peaks and valleys of Brickell Biotech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 423.39%
Maximum Annual PE Ratio = -0.17
Minimum Annual Increase = -88.98%
Minimum Annual PE Ratio = -5.65
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -0.91 | 347.78% |
| 2022 | -0.20 | -56.38% |
| 2021 | -0.47 | -48.90% |
| 2020 | -0.91 | 423.39% |
| 2019 | -0.17 | -88.98% |
| 2018 | -1.59 | -15.18% |
| 2017 | -1.87 | -27.20% |
| 2016 | -2.57 | -36.93% |
| 2015 | -4.07 | -27.97% |
| 2014 | -5.65 | 72.32% |
The current PE Ratio of Brickell Biotech, Inc. (BBI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.53
5-year avg
-0.53
10-year avg
-1.84
Brickell Biotech, Inc.’s PE Ratio is less than Kineta, Inc. (-0.96), less than Omega Therapeutics, Inc. (-0.24), less than Tvardi Therapeutics, Inc. (-2.68), less than Entero Therapeutics, Inc. (-0.21), greater than Star Equity Holdings, Inc. (-18.36), less than Biora Therapeutics, Inc. (-0.07), less than Tricida, Inc. (-0.03), less than Turnstone Biologics Corp. (-0.17), less than Longevity Health Holdings Inc. (-0.13), less than COSCIENS Biopharma Inc. (-0.36),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.96 | $7.05M | |
| -0.24 | $7.90M | |
| -2.68 | $37.34M | |
| -0.21 | $9.44M | |
| -18.36 | $38.04M | |
| -0.07 | $994.99K | |
| -0.03 | $5.95M | |
| -0.17 | $8.21M | |
| -0.13 | $638.01K | |
| -0.36 | $6.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Brickell Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Brickell Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Brickell Biotech, Inc.'s PE Ratio?
How is the PE Ratio calculated for Brickell Biotech, Inc. (BBI)?
What is the highest PE Ratio for Brickell Biotech, Inc. (BBI)?
What is the 3-year average PE Ratio for Brickell Biotech, Inc. (BBI)?
What is the 5-year average PE Ratio for Brickell Biotech, Inc. (BBI)?
How does the current PE Ratio for Brickell Biotech, Inc. (BBI) compare to its historical average?